Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
37 NC counties and 1 VA county are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Program
WRAL In-Depth: We answer your questions about Project 2025 on WRAL at 7
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vigil Neuroscience, Inc. - Common Stock
(NQ:
VIGL
)
4.190
-0.110 (-2.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
186,823
Open
4.270
Bid (Size)
4.010 (5)
Ask (Size)
4.370 (1)
Prev. Close
4.300
Today's Range
4.050 - 4.280
52wk Range
2.470 - 9.610
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
June 27, 2024
Tonix Pharmaceuticals stock is falling on Thursday after the company announced a proposed public offering for shares of TNXP.
Via
InvestorPlace
Why Is Branchout Food (BOF) Stock Down 39% Today?
June 27, 2024
Branchout Food stock is down on Thursday after the company priced an offering of 1.75 million shares of BOF at 80 cents each.
Via
InvestorPlace
Performance
YTD
+20.75%
+20.75%
1 Month
-1.18%
-1.18%
3 Month
+43.49%
+43.49%
6 Month
+39.67%
+39.67%
1 Year
-54.95%
-54.95%
More News
Read More
Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?
June 27, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 27, 2024
Via
InvestorPlace
Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
June 27, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Neuroscience: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 12, 2024
Via
Benzinga
3 Penny Stocks With the Power to 10X Your $1k Investment: June Edition
June 11, 2024
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Via
InvestorPlace
Vigil Neuroscience to Present in Upcoming June Investor Conferences
May 30, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 08, 2024
Via
Benzinga
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
May 08, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
April 17, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
VIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 26, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
March 20, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
March 13, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
March 12, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024
March 06, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
February 29, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference
February 07, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
January 08, 2024
Via
Benzinga
Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
January 03, 2024
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.